FDA NDC Directory · JSON-LD · Markdown

Lunsumio Velo

NDC 50242-201 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameMosunetuzumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761263
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsMOSUNETUZUMAB (45 mg/mL)
Marketing started20251219
Package count1

External sources

Source: openFDA. Public-domain (CC0).